阵发性房颤患者经胺碘酮联合缬沙坦治疗的效果观察

王贵奇

（陕西省榆林市府谷县中医医院心血管内科，陕西 榆林，719499）

浏览次数：131次 下载次数：441次

摘要：

目的 探讨阵发性房颤患者经胺碘酮联合缬沙坦治疗的临床效果。方法 选择2012年1月至2014年12月在我院接受治疗的175例阵发性房颤患者为研究对象，随机分为观察组（88例）和对照组（87例）。观察组患者采用胺碘酮联合缬沙坦治疗，对照组患者单纯采用胺碘酮治疗，对比两组患者的治疗效果。结果 观察组患者各时间段的窦性心律维持率均明显高于对照组患者，差异具有统计学意义（P<.05）。两组患者的不良反应发生率比较，差异不显著（P>.05）。结论 用胺碘酮联合缬沙坦治疗阵发性房颤能够有效维持窦性心律，且不会增加不良反应，安全可靠，值得推广使用。

关键词：阵发性房颤；胺碘酮；缬沙坦；窦性心律

中图分类号：R541.75文献标志码：A文章编号：2096-1413(2017)14-0034-02

Effect observation of amiodarone combined with valsartan on patients with paroxysmal atrial fibrillation
WANG Gui-qi
(Department of Cardiology, Traditional Chinese Medicine Hospital of Fugu County, Yulin 719499, China)

ABSTRACT: Objective To explore the clinical effect of amiodarone combined with valsartan on patients with paroxysmal atrial fibrillation. Methods One hundred and seventy -five patients with paroxysmal atrial fibrillation admitted in our hospital from January 2012 to December 2014 were selected and randomly divided into observation group (n =88) and control group (n=87). The observation group was treated with amiodarone combined with valsartan, the control group was treated with amiodarone. The treatment effects of the two groups were compared. Results The maintenance rate of sinus rhythm in the observation group was significantly higher than that in the control group, the difference was statistically significant (P<.05). There was no significant difference on the incidence rate of adverse reactions between the two groups (P>0.05). Conclusion Amiodarone combined with valsartan in the treatment of paroxysmal atrial fibrillation can effectively maintain sinus rhythm, and does not increase the incidence of adverse reactions. It`s safe and reliable, which is worthy of application and popularization in clinic.
KEYWORDS: paroxysmal atrial fibrillation; amiodarone; valsartan; sinus rhythm

参考文献：
[1] 梁海军.胺碘酮联合缬沙坦治疗老年阵发性房颤患者的疗效[J].中国老年学杂志,2014,34(4):1040-1041.
[2] 王桂萍,方伟钧,潘锋君,等.胺碘酮联合缬沙坦治疗老年阵发性心房颤动的临床观察[J].中国药房,2015,26(36):5102-5104.
[3] 高岩.胺碘酮联合缬沙坦治疗阵发性房颤应用价值评析[J].中国现代药物应用,2016,10(3):131-132.
[4] 蒋永春,徐斌.胺碘酮联合缬沙坦对老年持续性房颤患者的临床疗效[J].天津药学,2016,28(1):28-30.
[5] 唐慧莉.缬沙坦联合胺碘酮治疗慢性心力衰竭合并室性早搏的临床研究[J].实用药物与临床,2014,17(2):147-150.
[6] 高云,黄进,丁红梓,等.缬沙坦治疗慢性心力衰竭合并室性早搏的临床观察[J].实用临床医药杂志,2014,18(17):112-114.
[7] 旷吉琳,李莉,朱丽萍,等.治疗心血管疾病药物使用情况的调查分析[J].临床合理用药杂志,2014,7(3):14-15.
[8] 孙汉泽,孙智魁.阿托伐他汀联合胺碘酮预防阵发性房颤的临床观察[J].现代实用医学,2014,26(3):278-279.
[9] 杜娟.胺碘酮与阿托伐他汀联合治疗阵发性心房颤动的疗效分析[J].内蒙古中医药,2014,33(12):32-33.
[10] 王敬科.45 例阵发性房颤患者静脉注射胺碘酮转复的临床分析[J].内科急危重症杂志,2014,20(4):253-254.